Clinical Trial Update: A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) [Phase 1]

View source ↗

Summary

Phase 1 trial of robatumumab (SCH 717454, MK-7454) in combination with different regimens in pediatric participants with advanced solid tumors was terminated; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Cancer
• Kidney Tumor
• Neoplasms
• Neuroblastoma
• Solid Tumors

Drugs mentioned

• robatumumab (robatumumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms, Solid Tumors | Phase 1 | Status: TERMINATED | Results posted: 2016-02-10